D Amp M Pharma Peru Sac -

D & M Pharma Peru SAC: A Comprehensive Overview of Pharmaceutical Distribution in Peru

Fostering Strategic Alliances

D&M Pharma Peru S.A.C. serves as a vital bridge between international pharmaceutical innovators and the local healthcare community. By acting as a local representative for foreign partners, the company eliminates the barriers to entry for international brands. This symbiotic relationship allows global manufacturers to tap into Peru’s growing market while providing Peruvian patients with access to cutting-edge therapies and generic alternatives.

2. Potential Business Activities (Inferred)

While specific operational details are not public without a full SUNAT (Peru’s tax authority) or Registros Públicos search, companies with “Pharma” in their name in Peru typically register for activities such as:

1. Generic and Branded Generics

Focusing on high-volume medications such as antibiotics, antihypertensives, and antidiabetics, the company leverages Peru’s growing demand for affordable yet high-quality generics. They often partner with Indian, Chinese, and Colombian active pharmaceutical ingredient (API) manufacturers.

Looking Ahead

As Peru continues to strengthen its healthcare infrastructure, D & M Pharma Peru SAC remains at the forefront, embracing innovation, digital transformation, and continuous training. The goal is not just to grow as a business, but to contribute actively to the well-being of every Peruvian citizen.


D & M Pharma Peru SAC
Trust. Quality. Commitment to health.

(Insert contact details, RUC number, and physical address as applicable)

D & M Pharma Peru S.A.C. is a pharmaceutical wholesale and distribution company based in Lima, Peru. Established in 2007, the company operates as a key regional partner for international laboratories, most notably the Argentine firm Laboratorio Cassará. Company Overview

Sector: Wholesale of miscellaneous nondurable goods (pharmaceuticals).

Headquarters: Av. Pablo Carriquiry 660, Piso 3, Urb. Corpac, San Isidro (or San Borja), Lima, Peru. Size: Employs approximately 32 people as of 2024.

Key Affiliations: It is a strategic partner for Laboratorio Cassará, launching their product lines in Peru to expand international presence. Core Strengths

Regulatory Leadership: The company's Technical Director and Head of Quality Assurance, Dr. Mery Luz Peña García, holds a leadership role in the Pharmaceutical Sector of the Lima Chamber of Commerce (COMSALUD) for the 2026–2027 term, signaling strong industry influence and compliance standards.

Focus on Quality & Ethics: Their stated mission emphasizes providing safe, effective, and accessible medications backed by international expertise and social responsibility.

Established Tenure: With nearly two decades of operation in the Peruvian market, the firm has demonstrated stability and growth since its local start in 2006. Services & Reach

Distribution: Acts as a "Droguería" (drugstore/wholesaler), managing the logistics and marketing of pharmaceutical developments.

Pharmacovigilance: Maintains dedicated channels for drug safety monitoring and reporting, essential for maintaining pharmaceutical standards in Peru. Summary Verdict

D & M Pharma Peru S.A.C. appears to be a reputable, mid-sized distributor with significant ties to established Latin American pharmaceutical manufacturers. While it is not a "Big Pharma" giant, its active participation in regulatory bodies like the Lima Chamber of Commerce suggests it is a professional and compliant player in the Peruvian healthcare supply chain. D & M Pharma Peru S.A.C. Company Profile - EMIS

D&M Pharma Perú S.A.C. is a specialized pharmaceutical company based in Lima, Peru, that focuses on the distribution and marketing of high-quality therapeutic solutions. Established in 2006, the company acts as a strategic gateway for international pharmaceutical lines—most notably the Argentine Laboratorio Cassará —to reach the Peruvian healthcare market. Corporate Identity and Strategic Origins

D&M Pharma (short for "Desarrollos y Marketing Farmacéutico") was originally founded in Chile in 2003 by executives with extensive industry expertise. International Partnership:

In 2005, the company formed a partnership with Laboratorio Cassará, a prestigious Argentine laboratory with over 75 years of experience. Peruvian Launch: The company officially began operations in Peru in August 2007

(though its presence dates to 2006) to consolidate its international reach through the Cassará line. Current Scale:

As of late 2024, the enterprise operates with a team of approximately 32 employees out of its headquarters in San Isidro, Lima Therapeutic Specializations

The company’s portfolio is defined by its collaboration with various specialized divisions, providing medical professionals and patients with targeted treatments: Respiratory & Aerosol Therapy:

Recognized across Latin America for advanced treatments in asthma and other pulmonary conditions. Dermatology: Through divisions like Fouchard, Bailleul, and Feelderm d amp m pharma peru sac

, they offer specialized skin care and clinical dermatological products. Ophthalmology: Managed under the Biotecnología:

Integration of biotechnology into their medicinal development, particularly through the Cassará division. Regulatory Compliance & Quality Standards

D&M Pharma Perú operates under strict adherence to national and international pharmaceutical standards. Standards: They follow the Good Storage Practices (BPA)

and technical norms established by the Peruvian Ministry of Health. Pharmacovigilance:

The company maintains robust drug safety protocols to monitor and report adverse events to the (the Peruvian regulatory authority). Recent Leadership & Recognition

The company continues to hold a significant voice in the Peruvian health sector. Notably, in April 2026 , the company's Technical Director, Dra. Mery Luz Peña García

, was elected as Vice President of the Medicines Sector Board for the COMSALUD Gremio de Salud of the Lima Chamber of Commerce. or information on how to contact their regulatory department D & M Pharma Peru S.A.C. Company Profile - EMIS 31-Oct-2024 —

D Amp M Pharma Peru SAC is a significant player in the pharmaceutical landscape of Peru, specializing in the importation, distribution, and marketing of high-quality health products. As the Peruvian healthcare market continues to expand due to increased investment and a growing middle class, companies like D Amp M Pharma Peru SAC provide the essential bridge between global medical innovations and local patient needs.

The company operates under strict regulatory frameworks, ensuring that all products meet the standards set by DIGEMID (Dirección General de Medicamentos, Insumos y Drogas). This commitment to compliance is a cornerstone of their business model, allowing them to maintain trust with pharmacies, hospitals, and clinics across the country. By focusing on a diverse portfolio that often includes both generic and specialized medications, they address a wide spectrum of health concerns prevalent in the Andean region.

Strategically located in Lima, D Amp M Pharma Peru SAC leverages the city's logistical advantages to manage an efficient supply chain. Their infrastructure is designed to handle sensitive pharmaceutical goods, maintaining the cold chain where necessary to preserve product efficacy. This logistical prowess is vital in a country with diverse geography, where getting medicine from the capital to remote provinces can be a major challenge.

In addition to distribution, the company often engages in strategic partnerships with international laboratories looking to enter the Peruvian market. These collaborators rely on D Amp M Pharma's deep understanding of local market trends, consumer behavior, and the complex legal landscape. By acting as a local representative, the company facilitates the registration and commercialization of new treatments, bringing better health outcomes to the Peruvian population.

The corporate philosophy of D Amp M Pharma Peru SAC centers on accessibility and reliability. In a market where healthcare costs can be a barrier for many, the company strives to provide cost-effective solutions without compromising on the quality of the active ingredients. This balance of affordability and excellence has helped them carve out a reputable niche in a competitive industry.

As the digital transformation hits the pharmaceutical sector, D Amp M Pharma Peru SAC is also adapting to modern demands. This includes improving their inventory management systems and exploring digital channels for B2B transactions. Their ability to evolve with technological trends ensures that they remain a resilient and forward-thinking entity in Peru's medical supply sector.

In summary, D Amp M Pharma Peru SAC is more than just a distributor; it is a vital component of the Peruvian health ecosystem. Through rigorous quality control, expert logistical management, and a commitment to public health, the company continues to play a pivotal role in ensuring that safe and effective medicine is available to those who need it most throughout Peru.

D&M Pharma Peru SAC: A Leader in the Peruvian Pharmaceutical Industry

D&M Pharma Peru SAC is a prominent player in the Peruvian pharmaceutical market, specializing in the development, manufacturing, and marketing of high-quality pharmaceutical products. With a strong commitment to innovation, quality, and customer satisfaction, the company has established itself as a trusted partner for healthcare professionals and patients across the country.

History and Background

Founded in [Year], D&M Pharma Peru SAC has rapidly grown to become one of the leading pharmaceutical companies in Peru. The company's founders, [Founders' Names], brought with them a wealth of experience and expertise in the pharmaceutical industry, which has enabled D&M Pharma to navigate the complex and ever-changing landscape of the sector.

Product Portfolio

D&M Pharma Peru SAC boasts an extensive product portfolio that caters to a wide range of therapeutic areas, including cardiovascular, respiratory, gastrointestinal, and infectious diseases, among others. The company's product line includes a mix of prescription and over-the-counter (OTC) medications, ensuring that patients have access to affordable and effective treatment options.

Some of the company's flagship products include [Product Names], which have gained significant market share and recognition among healthcare professionals and patients. D&M Pharma's products are manufactured in state-of-the-art facilities, adhering to strict quality control and assurance protocols that meet or exceed international standards.

Research and Development

At D&M Pharma Peru SAC, research and development (R&D) is a top priority. The company's R&D team is comprised of experienced scientists and researchers who focus on developing innovative products that address the evolving healthcare needs of the Peruvian population. By investing in R&D, D&M Pharma aims to stay ahead of the curve and bring new and improved treatment options to the market.

Quality and Regulatory Compliance

D&M Pharma Peru SAC is committed to ensuring the highest standards of quality and regulatory compliance. The company's manufacturing facilities are accredited by regulatory agencies, such as the Peruvian Ministry of Health and the National Sanitary Control and Surveillance Agency (ANVISA). D&M Pharma's quality management system is certified to ISO 9001, demonstrating its dedication to quality and customer satisfaction.

Social Responsibility

As a responsible corporate citizen, D&M Pharma Peru SAC is engaged in various social responsibility initiatives that promote health, education, and community well-being. The company supports programs aimed at improving access to healthcare, particularly in underserved communities, and partners with local organizations to promote health education and awareness.

Conclusion

D&M Pharma Peru SAC has established itself as a leader in the Peruvian pharmaceutical industry, driven by its commitment to innovation, quality, and customer satisfaction. With a strong product portfolio, a focus on R&D, and a dedication to social responsibility, the company is well-positioned to continue growing and contributing to the healthcare needs of the Peruvian population.

If you need more information or want me to add something, let me know!

Also, I want to mention that I don't have more information about the company, if you want me to add or change something please provide me with more details.

D & M Pharma Peru S.A.C. is a registered pharmaceutical and wholesale enterprise based in Lima, Peru. While the company itself is a commercial entity rather than a research institution, its name or products may appear in technical documentation or regulatory filings within the Peruvian pharmaceutical sector. Company Overview Official Name: D & M Pharma Peru S.A.C.

Sector: Wholesale trade of miscellaneous nondurable goods, specifically pharmaceutical and medicinal products.

Headquarters: Av. Pablo Carriquiry 660, Piso 3, Urb. Corpac, San Isidro, Lima, Peru. Established: August 1, 2007. Contextual "Papers" and Documentation

If you are looking for formal papers related to this company, they typically fall into these categories:

Commercial & Financial Reports: Detailed business profiles, including financial data from 2022 and employee counts, are available through platforms like EMIS (D & M Pharma Peru S.A.C. Profile).

Regulatory Filings: As a pharmaceutical wholesaler, the company must comply with the General Directorate of Medicines, Supplies and Drugs (DIGEMID), which is the national regulatory authority in Peru. Any "papers" regarding product registrations or sanitary permits would be filed through this agency.

Research Context: While D & M Pharma is not the primary author of academic papers, it operates within a market frequently studied for trends like self-medication with antibiotics and the regulation of medicinal cannabis. D & M Pharma Peru S.A.C. Company Profile - EMIS

D&M Pharma Peru S.A.C. is a privately held pharmaceutical enterprise headquartered in Lima, Peru, specializing in the commercialization of respiratory and dermatological products. D&M Pharma Perú S.A.C. Pharmaceutical lab ClosedSan Isidro, Peru Directions Company Overview

Incorporation: The company was officially incorporated on August 1, 2007.

Operations: It serves as the authorized representative in Peru for the commercialization of pharmaceutical products, medical devices, and sanitary products from Laboratorio Pablo Cassará (Argentina) and Laboratorio D&M Pharma (Chile).

Scale: As of 2024, the enterprise employs approximately 32 people. RUC (Tax ID): 20514898961. Products and Specialties

D&M Pharma focuses on delivering safe and effective medications across several therapeutic areas:

Respiratory: Products such as Neumocort HFA and Aerotrop for inhalation and nebulization. D & M Pharma Peru SAC: A Comprehensive

Dermatology: A wide range including Atopix (creams and emulsions), Adapac (gel), and Fusimed.

Other Areas: Also provides solutions in Ophthalmology (Novoplos line) and Gastrointestinal health (Biocass probiotics). Market Position and Activities

Sector: Primarily operates in the Miscellaneous Nondurable Goods Merchant Wholesalers sector.

International Ties: Part of the D&M Pharma Group, which started in Chile in 2003 and expanded into Peru in 2006, and later into Ecuador in 2019.

Compliance: The company adheres to Good Storage Practices (BPA) and local Peruvian technical standards to ensure pharmaceutical quality. D&M Pharma Perú S.A.C.

D & M Pharma Peru S.A.C.: A Key Player in Peru's Pharmaceutical Sector

D & M Pharma Peru S.A.C. is a prominent pharmaceutical enterprise based in Lima, Peru, specializing in the distribution and marketing of high-quality medicinal products. Incorporated on August 01, 2007, the company has established itself as a reliable partner in the Peruvian healthcare system, particularly through its strategic alliance with the Argentine Laboratorio Cassará. Company Overview and Origins

D & M Pharma began its journey in Peru in 2006, following its initial founding in Chile in 2003 by executives with extensive experience in the pharmaceutical industry. The company operates primarily as a wholesaler of miscellaneous nondurable goods, focusing on the pharmaceutical sector.

Strategic Alliance: In 2005, the company partnered with Laboratorio Cassará, an Argentine laboratory with over 65 years of experience.

Mission: Their core objective is to provide safe, effective, and accessible medications that improve patient quality of life while supporting medical professionals.

Workforce: As of 2024, the company employs approximately 32 professionals dedicated to quality assurance and pharmaceutical marketing. Specialized Therapeutic Areas

D & M Pharma Peru S.A.C. focuses on specific medical niches, ensuring specialized care and high-standard products in the following areas:

Respiratory: Providing advanced solutions for pulmonary and airway conditions.

Dermatology: Offering a wide range of topical treatments and dermocosmetic products.

Ophthalmology: Managed through their specialized division, Novoplos.

Biotechnology: Leveraging modern science to provide innovative treatments. Key Products and Divisions

The company organizes its portfolio through five primary divisions, each dedicated to specific health needs:

Cassará: Covers dermatology, respiratory, and biotechnology lines.

Fouchard, Bailleul, and Feelderm: Specialized divisions for advanced dermatological care. Novoplos: Focused on ophthalmological solutions.

Specific products distributed by the group include Adapac (gel), Aerotrop (nebulization solutions), Anagen (capillary lotion), and Atopix (creams and emulsions). Quality Assurance and Pharmacovigilance

Patient safety is a cornerstone of operations at D & M Pharma Peru S.A.C.. The company maintains a robust Pharmacovigilance system to monitor and report adverse events, ensuring all distributed medications meet international safety standards. Recently, their Technical Director, Dr. Mery Luz Peña García, was elected as Vice President of the Drug Sector for the Chamber of Commerce of Lima for the 2026–2027 period, reflecting the company’s leadership in quality standards. Contact Information and Headquarters

For professional inquiries or pharmacovigilance reporting, the company can be reached at their central office in Lima: Wholesale of pharmaceutical products (CIIU code 4640

Address: Av. Pablo Carriquiry 660, Piso 3, San Isidro, Lima, Peru. Phone: +51 1 2216662 or toll-free at 0800 74074. Email: farmacovigilancia@dympharmaperu.com. Av. Pablo Carriquiry 660, Piso 3, San Isidro, Lima, Peru D & M Pharma Peru S.A.C. Company Profile - EMIS

1. Importation of Pharmaceuticals

D & M Pharma Peru SAC likely acts as an intermediary between international laboratories (European, Indian, or Chinese manufacturers) and the local market. Given Peru’s reliance on imported medicine (over 85% of APIs are imported), the company’s logistics chain is critical. They must adhere to Good Distribution Practices (GDP) certified by the DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) .